Photo from wikipedia
Patients with optic neuritis (ON) have significant individual differences in their response to high‐dose intravenous methylprednisolone (HIMP) therapy. This study aims to evaluate the association between gene polymorphisms and the… Click to show full abstract
Patients with optic neuritis (ON) have significant individual differences in their response to high‐dose intravenous methylprednisolone (HIMP) therapy. This study aims to evaluate the association between gene polymorphisms and the efficacy of HIMP therapy in Chinese Han patients with ON mediated by aquaporin‐4 immunoglobulin G antibody (AQP4‐IgG) ‐positive neuromyelitis optica spectrum disorder (NMOSD) or multiple sclerosis (MS).
Keywords:
therapy;
gene polymorphisms;
optic neuritis;
dose intravenous;
intravenous methylprednisolone;
high dose
Journal Title: Journal of Clinical Pharmacy and Therapeutics
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Clinical Pharmacy and Therapeutics
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!